Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 3 Patient characteristics

From: Impact of an enhanced recovery pathway on length of stay and complications in elective radical cystectomy: a before and after cohort study

  Historical control (N = 100) ERAS patients (N = 100) p value
Gender (male) 79 (79.00%) 69 (69.00%) 0.1071
Age 68.00 [69.75, 77.00] 66 [61.00, 72.25] 0.3602
BMI (kg/m2) 26.88 [24.22, 30.47] 27.83 [24.83, 31.58] 0.5672
ASA class    0.3311
 ASA 1 0 (0.00%) 1 (1.00%)  
 ASA 2 12 (12.00%) 7 (7.00%)  
 ASA 3 81 (81.00%) 88 (88.00%)  
 ASA 4 7 (7.00%) 4 (4.00%)  
Smoker    0.0171
 Current smoker 20 (20.00%) 8 (8.00%)  
 Former smoker 62 (62.00%) 62 (62.00%)  
 Never smoker 18 (18.00%) 30 (30.00%)  
Diabetes mellitus 27 (27.00%) 25 (25.00%) 0.7471
Diabetes control    0.2411
 Medically treated 25 (96.15%) 20 (86.96%)  
 Diet controlled 1 (3.85%) 3 (13.04%)  
History of cardiac disease 68 (68.00%) 72 (72.00%) 0.5371
History of respiratory disease 42 (42.00%) 39 (39.00%) 0.6661
Preoperative hemoglobin (g/dL) 11.20 [9.70, 13.05] 12.00 [10.10, 13.30] 0.1552
Preoperative white blood cell count (g/dL) 8.30 [6.60, 11.20] 7.70 [6.15, 9.85] 0.1122
Preoperative creatinine (g/dL) 1.20 [0.95, 1.70] 1.10 [0.90, 1.40] 0.0752
  1. Continuous variables reported as median [Q1, Q3]; categorical variables reported as count and percent
  2. History of cardiac disease includes MI, angina, pulmonary edema, cardiac treatment, peripheral edema, and other unspecified
  3. History of respiratory disease includes chronic obstructive pulmonary disease, asthma, mild or limiting dyspnea, dyspnea at rest, home oxygen use, sleep apnea, and other unspecified
  4. p value key: 1Chi-square, 2Wilcoxon